Literature DB >> 25495411

Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole.

Manuel Román1, Dolores Ochoa, Sergio Daniel Sánchez-Rojas, Maria Talegón, Rocio Prieto-Pérez, Ângela Rivas, Francisco Abad-Santos, Teresa Cabaleiro.   

Abstract

AIM: To evaluate the possible association between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, rabeprazole and pantoprazole. MATERIALS &
METHODS: 151 healthy volunteers were evaluated for polymorphisms in the CYP2C19 gene using real-time polymerase chain reaction. Plasma concentrations were measured using high-performance liquid chromatography coupled to mass spectrometry.
RESULTS: Carriers of the *2 allele displayed poor metabolism for all the PPIs studied (around 50% decrease in clearance). Subjects with the *17 allele showed a light increase in clearance compared with *1/*1 (not significant).
CONCLUSION: CYP2C19*2 is associated with decreased clearance of all the PPIs, that could be associated with higher drug efficacy. CYP2C19*17 could increase clearance of these drugs, although the effect seems small.

Entities:  

Keywords:  CYP2C19; pharmacogenetics; pharmacokinetics; proton-pump inhibitors

Mesh:

Substances:

Year:  2014        PMID: 25495411     DOI: 10.2217/pgs.14.141

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  11 in total

Review 1.  Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.

Authors:  I Fricke-Galindo; C Céspedes-Garro; F Rodrigues-Soares; M E G Naranjo; Á Delgado; F de Andrés; M López-López; E Peñas-Lledó; A LLerena
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

2.  Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects.

Authors:  Sijie Lu; R A Nand; J S Yang; Gang Chen; A S Gross
Journal:  Eur J Clin Pharmacol       Date:  2017-11-27       Impact factor: 2.953

3.  Antagonism of Fluconazole and a Proton Pump Inhibitor against Candida albicans.

Authors:  Ning-Ning Liu; Julia R Köhler
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

4.  Blockade of Cardiac Proton Pump Impairs Ventricular Remodeling Through a Superoxide-DDAH-Dependent Pathway in Infarcted Rats.

Authors:  Wei-Ting Chen; Chang-Bie Shie; Chen-Chia Yang; Tsung-Ming Lee
Journal:  Acta Cardiol Sin       Date:  2019-03       Impact factor: 2.672

5.  A Decade of Pharmacogenetic Studies in Jordan: A Systemic Review.

Authors:  Alaa Yehya; Zaid Altaany
Journal:  Pharmacogenomics J       Date:  2021-04-13       Impact factor: 3.550

6.  Precision medication: An illustrative case series guiding the clinical application of multi-drug interactions and pharmacogenomics.

Authors:  Kevin T Bain; David McGain; Emily J Cicali; Calvin H Knowlton; Veronique Michaud; Jacques Turgeon
Journal:  Clin Case Rep       Date:  2019-12-23

7.  Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole.

Authors:  Dolores Ochoa; Manuel Román; Teresa Cabaleiro; Miriam Saiz-Rodríguez; Gina Mejía; Francisco Abad-Santos
Journal:  BMC Pharmacol Toxicol       Date:  2020-07-25       Impact factor: 2.483

8.  Enriching Medication Review with a Pharmacogenetic Profile - A Case of Tamoxifen Adverse Drug Reactions.

Authors:  Chiara Jeiziner; Céline K Stäuble; Markus L Lampert; Kurt E Hersberger; Henriette E Meyer Zu Schwabedissen
Journal:  Pharmgenomics Pers Med       Date:  2021-02-19

9.  A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice.

Authors:  Chao-Hung Kuo; Chung-Jung Liu; Ching-Chia Yang; Fu-Chen Kuo; Huang-Ming Hu; Hsiang-Yao Shih; Meng-Chieh Wu; Yen-Hsu Chen; Hui-Min David Wang; Jian-Lin Ren; Deng-Chyang Wu; Lin-Li Chang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

10.  Effect of CYP2C19 Gene Polymorphisms on Proton Pump Inhibitor, Amoxicillin, and Levofloxacin Triple Therapy for Eradication of Helicobacter Pylori.

Authors:  Yun-An Lin; Hong Wang; Zhu-Jun Gu; Wen-Jia Wang; Xiao-Yan Zeng; Yan-Lei Du; Song-Song Ying; Bo-Hua Zhang
Journal:  Med Sci Monit       Date:  2017-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.